Treatment Concepts for Wake-Up Stroke and Stroke with Unknown Time of Symptom Onset

Stroke

Volumn 46, Issue 9, 2015, Pages 2707-2713

  Thomalla, Götz ^a   Gerloff, Christian ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; HUMAN; MEDICAL INFORMATION; MULTICENTER STUDY (TOPIC); NEUROIMAGING; PERFUSION WEIGHTED IMAGING; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION; REVIEW; WAKE UP STROKE; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; PHYSIOLOGY; PROCEDURES; STROKE; WAKEFULNESS;

ENDOVASCULAR PROCEDURES; HUMANS; REPERFUSION; STROKE; THROMBOLYTIC THERAPY; WAKEFULNESS;

EID: 84940434572     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.009701     Document Type: Review

References (41)

1. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947. doi: 10.1161/STR. 0b013e318284056a.
2. ESO. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457-507.
3. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11-20. doi: 10.1056/NEJMoa1411587.
4. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009-1018. doi: 10.1056/NEJMoa1414792.
5. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019-1030. doi: 10.1056/NEJMoa1414905.
6. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296-2306. doi: 10.1056/NEJMoa1503780.
7. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al; SWIFT PRIME Investigators. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. Int J Stroke. 2015;10:439-448. doi: 10.1111/ijs.12459.
8. Serena J, Dávalos A, Segura T, Mostacero E, Castillo J. Stroke on awakening: looking for a more rational management. Cerebrovasc Dis. 2003;16:128-133. doi: 70592.
9. Mackey J, Kleindorfer D, Sucharew H, Moomaw CJ, Kissela BM, Alwell K, et al. Population-based study of wake-up strokes. Neurology. 2011;76:1662-1667. doi: 10.1212/WNL.0b013e318219fb30.
10. Moradiya Y, Janjua N. Presentation and outcomes of "wake-up strokes" in a large randomized stroke trial: analysis of data from the International Stroke Trial. J Stroke Cerebrovasc Dis. 2013;22:e286-e292. doi: 10.1016/j.jstrokecerebrovasdis.2012.07.016.
11. Reid JM, Dai D, Cheripelli B, Christian C, Reidy Y, Gubitz GJ, et al. Differences in wake-up and unknown onset stroke examined in a stroke registry. Int J Stroke. 2015;10:331-335. doi: 10.1111/ijs.12388.
12. Roveri L, La Gioia S, Ghidinelli C, Anzalone N, De Filippis C, Comi G. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke. J Stroke Cerebrovasc Dis. 2013;22:703-708. doi: 10.1016/j.jstrokecerebrovasdis.2011.10.003.
13. Silva GS, Lima FO, Camargo EC, Smith WS, Singhal AB, Greer DM, et al. Wake-up stroke: clinical and neuroimaging characteristics. Cerebrovasc Dis. 2010;29:336-342. doi: 10.1159/000278929.
14. Kim JT, Park MS, Nam TS, Choi SM, Kim BC, Kim MK, et al. Thrombolysis as a factor associated with favorable outcomes in patients with unclearonset stroke. Eur J Neurol. 2011;18:988-994. doi: 10.1111/j.1468-1331.2011.03351.x.
15. Manawadu D, Bodla S, Keep J, Jarosz J, Kalra L. An observational study of thrombolysis outcomes in wake-up ischemic stroke patients. Stroke. 2013;44:427-431. doi: 10.1161/STROKEAHA.112.673145.
16. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, et al; DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517. doi: 10.1002/ana.20976.
17. Thomalla G, Schwark C, Sobesky J, Bluhmki E, Fiebach JB, Fiehler J, et al; MRI in Acute Stroke Study Group of the German Competence Network Stroke. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke. 2006;37:852-858. doi: 10.1161/01.STR.0000204120.79399.72.
18. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke. 2009;40:469-475. doi: 10.1161/STROKEAHA.108.526954.
19. Wintermark M, Flanders AE, Velthuis B, Meuli R, van Leeuwen M, Goldsher D, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke. 2006;37:979-985. doi: 10.1161/01.STR.0000209238.61459.39.
20. Campbell BC, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM, et al. Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke. 2011;42:3435-3440. doi: 10.1161/STROKEAHA.111.618355.
21. Thomalla G, Rossbach P, Rosenkranz M, Siemonsen S, Krützelmann A, Fiehler J, et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol. 2009;65:724-732. doi: 10.1002/ana.21651.
22. Thomalla G, Cheng B, Ebinger M, Hao Q, Tourdias T, Wu O, et al; STIR and VISTA Imaging Investigators. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol. 2011;10:978-986. doi: 10.1016/S1474-4422(11)70192-2.
23. Buck D, Shaw LC, Price CI, Ford GA. Reperfusion therapies for wakeup stroke: systematic review. Stroke. 2014;45:1869-1875. doi: 10.1161/STROKEAHA.114.005126.
24. Breuer L, Schellinger PD, Huttner HB, Halwachs R, Engelhorn T, Doerfler A, et al. Feasibility and safety of magnetic resonance imaging-based thrombolysis in patients with stroke on awakening: initial single-centre experience. Int J Stroke. 2010;5:68-73. doi: 10.1111/j.1747-4949.2010.00410.x.
25. Ebinger M, Scheitz JF, Kufner A, Endres M, Fiebach JB, Nolte CH. MRI-based intravenous thrombolysis in stroke patients with unknown time of symptom onset. Eur J Neurol. 2012;19:348-350. doi: 10.1111/j.1468-1331.2011.03504.x.
26. Aoki J, Kimura K, Iguchi Y, Shibazaki K, Iwanaga T, Watanabe M, et al. Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time. Cerebrovasc Dis. 2011;31:435-441. doi: 10.1159/000323850.
27. Bai Q, Zhao Z, Fu P, Sui H, Xie X, Chen J, et al. Clinical outcomes of fast MRI-based trombolysis in wake-up strokes compared to superacute ischemic strokes within 12 hours. Neurol Res. 2013;35:492-497. doi: 10.1179/1743132813Y.0000000208.
28. Cho AH, Sohn SI, Han MK, Lee DH, Kim JS, Choi CG, et al. Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis. 2008;25:572-579. doi: 10.1159/000132204.
29. Kang DW, Sohn SI, Hong KS, Yu KH, Hwang YH, Han MK, et al. Reperfusion therapy in unclear-onset stroke based on MRI evaluation (RESTORE): a prospective multicenter study. Stroke. 2012;43:3278-3283. doi: 10.1161/STROKEAHA.112.675926.
30. Michel P, Ntaios G, Reichhart M, Schindler C, Bogousslavsky J, Maeder P, et al. Perfusion-CT guided intravenous thrombolysis in patients with unknown-onset stroke: a randomized, double-blind, placebo-controlled, pilot feasibility trial. Neuroradiology. 2012;54:579-588. doi: 10.1007/s00234-011-0944-1.
31. Barreto AD, Martin-Schild S, Hallevi H, Morales MM, Abraham AT, Gonzales NR, et al. Thrombolytic therapy for patients who wake-up with stroke. Stroke. 2009;40:827-832. doi: 10.1161/STROKEAHA.108.528034.
32. Aghaebrahim A, Leiva-Salinas C, Jadhav AP, Jankowitz B, Zaidi S, Jumaa M, et al. Outcomes after endovascular treatment for anterior circulation stroke presenting as wake-up strokes are not different than those with witnessed onset beyond 8 hours [published online ahead of print October 17, 2014]. J Neurointerv Surg. http://jnis.bmj.com/content/early/2014/10/17/neurintsurg-2014-011316.long. Accessed July 1, 2015.
33. Jung S, Gralla J, Fischer U, Mono ML, Weck A, Lüdi R, et al. Safety of endovascular treatment beyond the 6-h time window in 205 patients. Eur J Neurol. 2013; 20:865-871. doi: 10.1111/ene.12069.
34. Mokin M, Kan P, Sivakanthan S, Veznedaroglu E, Binning MJ, Liebman KM, et al. Endovascular therapy of wake-up strokes in the modern era of stent retriever thrombectomy [published online ahead of print January 29, 2015]. J Neurointerv Surg. http://jnis.bmj.com/content/early/2015/01/29/neurintsurg-2014-011586.long. Accessed July 1, 2015.
35. Natarajan SK, Karmon Y, Snyder KV, Ohta H, Hauck EF, Hopkins LN, et al. Prospective acute ischemic stroke outcomes after endovascular therapy: a real-world experience. World Neurosurg. 2010; 74: 455-464. doi 10.1016/j.wneu.2010.06.035.
36. Stampfl S, Ringleb PA, Haehnel S, Rocco A, Herweh C, Hametner C, et al. Recanalization with stent-retriever devices in patients with wakeup stroke. AJNR Am J Neuroradiol. 2013;34:1040-1043. doi: 10.3174/ajnr.A3357.
37. Cho TH, Nighoghossian N, Tahon F, Némoz C, Hermier M, Salkine F, et al. Brain stem diffusion-weighted imaging lesion score: a potential marker of outcome in acute basilar artery occlusion. AJNR Am J Neuroradiol. 2009;30:194-198. doi: 10.3174/ajnr.A1278.
38. Ma H, Parsons MW, Christensen S, Campbell BC, Churilov L, Connelly A, et al; EXTEND investigators. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke. 2012;7:74-80. doi: 10.1111/j.1747-4949.2011.00730.x.
39. Logallo N, Kvistad CE, Nacu A, Naess H, Waje-Andreassen U, Asmuss J, et al. The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke. BMC Neurol. 2014;14:106. doi: 10.1186/1471-2377-14-106.
40. Koga M, Toyoda K, Kimura K, Yamamoto H, Sasaki M, Hamasaki T, et al; THAWS investigators. THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0.6 mg/kg (THAWS) Trial. Int J Stroke. 2014;9:1117-1124. doi: 10.1111/ijs.12360.
41. Thomalla G, Fiebach JB, Østergaard L, Pedraza S, Thijs V, Nighoghossian N, et al; WAKE-UP investigators. A multicenter, randomized, doubleblind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke. 2014;9:829-836. doi: 10.1111/ijs.12011.